Literature DB >> 34328790

T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus.

Ralph C Budd1, Christopher D Scharer2, Ramiro Barrantes-Reynolds3, Scott Legunn1, Karen A Fortner1.   

Abstract

Significance: Numerous abnormalities in T cells have been described in patients with systemic lupus erythematosus (SLE), including lymphopenia, DNA demethylation, expression of endogenous retroviruses (ERVs), increased cell death, enlarged mitochondria, production of reactive oxygen species (ROS), and the appearance of unusual CD4-CD8- T cells. Our studies propose a model in which accelerated homeostatic proliferation of T cells promotes an epigenetic and metabolic program, leading to this cluster of abnormalities. Recent Advances: Growing knowledge of the innate immune disorders in SLE has included increased mitochondrial size and ROS production that induces oligomerization of the mitochondrial antiviral signaling (MAVS) protein and type I interferon production, as well as DNA demethylation, upregulation of inflammatory genes, and expression of certain ERVs in SLE peripheral blood mononuclear cells. All these events are part of the cellular program that occurs during homeostatic proliferation of T cells. Evidence from a murine model of SLE as well as in human SLE reveals that increased T cell homeostatic proliferation may be a driving factor in these processes. Critical Issues: Despite extensive knowledge of the myriad autoantibodies in SLE and other immune abnormalities, a cogent model has been lacking to link the numerous and seemingly disparate immune aberrations. This may partly explain the general lack of new drugs specifically for SLE in over 50 years. A more coherent model of SLE would not only unify the variety of immune abnormalities is SLE but would also suggest new therapies. Future Directions: The model of augmented homeostatic proliferation leading to increased mitochondrial mass, ROS, DNA demethylation, and upregulation of inflammatory genes suggests strategic new targets for SLE, including antioxidants and certain inhibitors of metabolism. Antioxid. Redox Signal. 36, 410-422.

Entities:  

Keywords:  DNA methylation; MAVS; ROS; homeostatic proliferation; lupus

Mesh:

Year:  2021        PMID: 34328790      PMCID: PMC8982120          DOI: 10.1089/ars.2021.0078

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  105 in total

1.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

Review 2.  From T to B and back again: positive feedback in systemic autoimmune disease.

Authors:  M J Shlomchik; J E Craft; M J Mamula
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

3.  IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.

Authors:  F Mattei; G Schiavoni; F Belardelli; D F Tough
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells.

Authors:  Catarina M Henriques; José Rino; Robert J Nibbs; Gerry J Graham; João T Barata
Journal:  Blood       Date:  2010-02-26       Impact factor: 22.113

5.  Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes.

Authors:  S R Clarke; A Y Rudensky
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

6.  Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus.

Authors:  A Bengtsson; J Blomberg; O Nived; R Pipkorn; L Toth; G Sturfelt
Journal:  Arthritis Rheum       Date:  1996-10

Review 7.  Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus.

Authors:  Yiqun Zhang; Ming Zhao; Amr H Sawalha; Bruce Richardson; Qianjin Lu
Journal:  J Autoimmun       Date:  2013-01-20       Impact factor: 7.094

8.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

9.  Reduced development of CD4-8-B220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules.

Authors:  T Ohteki; M Iwamoto; S Izui; H R MacDonald
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

10.  Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.

Authors:  C T Ravirajan; Y Wang; L A Matis; L Papadaki; M H Griffiths; D S Latchman; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2004-01-06       Impact factor: 7.580

View more
  1 in total

Review 1.  Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment.

Authors:  Zhao Shan; Wei Hong Fa; Chen Run Tian; Chen Shi Yuan; Ning Jie
Journal:  Aging (Albany NY)       Date:  2022-03-24       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.